Ginkgo Bioworks Holdings, Inc. Class A Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • November 18th, 2022 • Ginkgo Bioworks Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 18th, 2022 Company Industry JurisdictionGinkgo Bioworks Holdings, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriter named in Schedule I hereto (the “Underwriter”) an aggregate of 41,383,877 shares (the “Firm Shares”) and, at the election of the Underwriter, up to 6,207,581 additional shares (the “Optional Shares”) of Class A common stock, par value $0.0001 per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriter elects to purchase pursuant to Section 2 hereof being collectively called the “Shares”).